nodes	percent_of_prediction	percent_of_DWPC	metapath
Pipotiazine—SLC22A1—prostate cancer	0.227	0.527	CbGaD
Pipotiazine—CYP2C19—prostate cancer	0.125	0.289	CbGaD
Pipotiazine—CYP3A4—prostate cancer	0.0794	0.184	CbGaD
Pipotiazine—ALB—Abiraterone—prostate cancer	0.038	0.0813	CbGbCtD
Pipotiazine—CYP2C19—Bicalutamide—prostate cancer	0.0297	0.0636	CbGbCtD
Pipotiazine—CYP2C19—Nilutamide—prostate cancer	0.0297	0.0636	CbGbCtD
Pipotiazine—ALB—Estrone—prostate cancer	0.0275	0.0588	CbGbCtD
Pipotiazine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0274	0.0585	CbGbCtD
Pipotiazine—SLC22A1—Estradiol—prostate cancer	0.027	0.0576	CbGbCtD
Pipotiazine—CYP2C19—Flutamide—prostate cancer	0.0246	0.0527	CbGbCtD
Pipotiazine—CYP1A2—Flutamide—prostate cancer	0.0227	0.0486	CbGbCtD
Pipotiazine—CYP2D6—Bicalutamide—prostate cancer	0.0226	0.0484	CbGbCtD
Pipotiazine—CYP2D6—Abiraterone—prostate cancer	0.0187	0.0401	CbGbCtD
Pipotiazine—CYP1A2—Estrone—prostate cancer	0.0164	0.0352	CbGbCtD
Pipotiazine—ALB—Estradiol—prostate cancer	0.0158	0.0338	CbGbCtD
Pipotiazine—CYP3A4—Bicalutamide—prostate cancer	0.0144	0.0308	CbGbCtD
Pipotiazine—ALB—Prednisone—prostate cancer	0.0136	0.029	CbGbCtD
Pipotiazine—CYP3A4—Estramustine—prostate cancer	0.0134	0.0286	CbGbCtD
Pipotiazine—CYP3A4—Abiraterone—prostate cancer	0.0119	0.0255	CbGbCtD
Pipotiazine—CYP3A4—Flutamide—prostate cancer	0.0119	0.0255	CbGbCtD
Pipotiazine—CYP1A2—Conjugated Estrogens—prostate cancer	0.0108	0.023	CbGbCtD
Pipotiazine—CYP2C19—Estradiol—prostate cancer	0.0102	0.0219	CbGbCtD
Pipotiazine—CYP1A2—Estradiol—prostate cancer	0.00944	0.0202	CbGbCtD
Pipotiazine—CYP3A4—Cabazitaxel—prostate cancer	0.00881	0.0188	CbGbCtD
Pipotiazine—CYP2C19—Prednisone—prostate cancer	0.0088	0.0188	CbGbCtD
Pipotiazine—CYP3A4—Estrone—prostate cancer	0.00861	0.0184	CbGbCtD
Pipotiazine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00768	0.0164	CbGbCtD
Pipotiazine—CYP1A2—Etoposide—prostate cancer	0.00617	0.0132	CbGbCtD
Pipotiazine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00564	0.0121	CbGbCtD
Pipotiazine—CYP3A4—Mitoxantrone—prostate cancer	0.00512	0.011	CbGbCtD
Pipotiazine—CYP3A4—Estradiol—prostate cancer	0.00495	0.0106	CbGbCtD
Pipotiazine—CYP3A4—Prednisone—prostate cancer	0.00425	0.0091	CbGbCtD
Pipotiazine—CYP2D6—Doxorubicin—prostate cancer	0.00347	0.00741	CbGbCtD
Pipotiazine—CYP3A4—Etoposide—prostate cancer	0.00323	0.00691	CbGbCtD
Pipotiazine—CYP3A4—Docetaxel—prostate cancer	0.00296	0.00632	CbGbCtD
Pipotiazine—CYP3A4—Doxorubicin—prostate cancer	0.0022	0.00471	CbGbCtD
Pipotiazine—CYP2C19—urine—prostate cancer	0.000972	0.175	CbGeAlD
Pipotiazine—CYP1A2—urine—prostate cancer	0.000794	0.143	CbGeAlD
Pipotiazine—HTR2A—urine—prostate cancer	0.000621	0.112	CbGeAlD
Pipotiazine—CYP3A4—urine—prostate cancer	0.000574	0.104	CbGeAlD
Pipotiazine—CYP2D6—urine—prostate cancer	0.000565	0.102	CbGeAlD
Pipotiazine—SLC22A1—renal system—prostate cancer	0.000308	0.0556	CbGeAlD
Pipotiazine—Perphenazine—AOX1—prostate cancer	0.00029	0.103	CrCbGaD
Pipotiazine—HTR1A—renal system—prostate cancer	0.000255	0.046	CbGeAlD
Pipotiazine—CYP1A2—renal system—prostate cancer	0.000194	0.035	CbGeAlD
Pipotiazine—ALB—testis—prostate cancer	0.000191	0.0344	CbGeAlD
Pipotiazine—Domperidone—CYP3A5—prostate cancer	0.000174	0.0619	CrCbGaD
Pipotiazine—HTR2A—epithelium—prostate cancer	0.000164	0.0295	CbGeAlD
Pipotiazine—Acepromazine—SLC22A1—prostate cancer	0.000161	0.0574	CrCbGaD
Pipotiazine—Thioproperazine—SLC22A1—prostate cancer	0.000157	0.0561	CrCbGaD
Pipotiazine—Thiothixene—SLC22A1—prostate cancer	0.000155	0.0552	CrCbGaD
Pipotiazine—HTR2A—renal system—prostate cancer	0.000152	0.0274	CbGeAlD
Pipotiazine—DRD2—testis—prostate cancer	0.000149	0.0268	CbGeAlD
Pipotiazine—CYP3A4—renal system—prostate cancer	0.000141	0.0254	CbGeAlD
Pipotiazine—ALB—lymph node—prostate cancer	0.000138	0.025	CbGeAlD
Pipotiazine—CYP2D6—renal system—prostate cancer	0.000138	0.025	CbGeAlD
Pipotiazine—Clomipramine—GSTP1—prostate cancer	0.000132	0.0472	CrCbGaD
Pipotiazine—Perphenazine—CYP2C18—prostate cancer	0.00013	0.0462	CrCbGaD
Pipotiazine—Imipramine—SLC22A3—prostate cancer	0.000116	0.0415	CrCbGaD
Pipotiazine—Imipramine—CYP2C18—prostate cancer	0.000102	0.0365	CrCbGaD
Pipotiazine—HTR2A—testis—prostate cancer	9.81e-05	0.0177	CbGeAlD
Pipotiazine—CYP2D6—testis—prostate cancer	8.94e-05	0.0161	CbGeAlD
Pipotiazine—Alimemazine—CYP3A4—prostate cancer	8.83e-05	0.0315	CrCbGaD
Pipotiazine—Chlorpromazine—SLC22A1—prostate cancer	8.39e-05	0.0299	CrCbGaD
Pipotiazine—Quetiapine—CYP3A5—prostate cancer	8.37e-05	0.0299	CrCbGaD
Pipotiazine—Imipramine—SLC22A1—prostate cancer	8.35e-05	0.0298	CrCbGaD
Pipotiazine—Mequitazine—CYP3A4—prostate cancer	7.6e-05	0.0271	CrCbGaD
Pipotiazine—Domperidone—CYP3A4—prostate cancer	7.51e-05	0.0268	CrCbGaD
Pipotiazine—Fluphenazine—CYP2E1—prostate cancer	7.42e-05	0.0265	CrCbGaD
Pipotiazine—Clomipramine—CYP2C19—prostate cancer	6.72e-05	0.024	CrCbGaD
Pipotiazine—Thioridazine—CYP2E1—prostate cancer	6.39e-05	0.0228	CrCbGaD
Pipotiazine—Thioridazine—CYP2C19—prostate cancer	6.33e-05	0.0226	CrCbGaD
Pipotiazine—Methotrimeprazine—CYP2E1—prostate cancer	6.1e-05	0.0218	CrCbGaD
Pipotiazine—Perphenazine—CYP2C19—prostate cancer	5.81e-05	0.0207	CrCbGaD
Pipotiazine—Quetiapine—CYP2C19—prostate cancer	5.7e-05	0.0203	CrCbGaD
Pipotiazine—Promazine—CYP2C19—prostate cancer	5.24e-05	0.0187	CrCbGaD
Pipotiazine—Prochlorperazine—CYP3A4—prostate cancer	5.17e-05	0.0184	CrCbGaD
Pipotiazine—Chlorpromazine—CYP2E1—prostate cancer	4.66e-05	0.0166	CrCbGaD
Pipotiazine—Imipramine—CYP2E1—prostate cancer	4.63e-05	0.0165	CrCbGaD
Pipotiazine—Imipramine—CYP2C19—prostate cancer	4.59e-05	0.0164	CrCbGaD
Pipotiazine—Clomipramine—CYP3A4—prostate cancer	4.27e-05	0.0152	CrCbGaD
Pipotiazine—Perphenazine—CYP3A4—prostate cancer	3.7e-05	0.0132	CrCbGaD
Pipotiazine—Quetiapine—CYP3A4—prostate cancer	3.62e-05	0.0129	CrCbGaD
Pipotiazine—Promazine—CYP3A4—prostate cancer	3.33e-05	0.0119	CrCbGaD
Pipotiazine—Chlorpromazine—CYP3A4—prostate cancer	2.93e-05	0.0105	CrCbGaD
Pipotiazine—Imipramine—CYP3A4—prostate cancer	2.92e-05	0.0104	CrCbGaD
Pipotiazine—DRD1—Signaling Pathways—CDKN1B—prostate cancer	2.9e-06	3.13e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—TYMS—prostate cancer	2.89e-06	3.12e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—NCOA1—prostate cancer	2.89e-06	3.12e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—INS—prostate cancer	2.88e-06	3.11e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—NOS3—prostate cancer	2.88e-06	3.1e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—GSK3B—prostate cancer	2.87e-06	3.1e-05	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—AKT1—prostate cancer	2.87e-06	3.09e-05	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—TP53—prostate cancer	2.87e-06	3.09e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—GSTM1—prostate cancer	2.86e-06	3.09e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.85e-06	3.07e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—CASP3—prostate cancer	2.84e-06	3.07e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—IL2—prostate cancer	2.84e-06	3.06e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—INS—prostate cancer	2.84e-06	3.06e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—CAV1—prostate cancer	2.82e-06	3.05e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—IL6—prostate cancer	2.82e-06	3.05e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.82e-06	3.05e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CREBBP—prostate cancer	2.82e-06	3.04e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PRKACB—prostate cancer	2.81e-06	3.03e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—LPL—prostate cancer	2.81e-06	3.03e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—JAK2—prostate cancer	2.8e-06	3.02e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—IGF1—prostate cancer	2.79e-06	3.01e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.78e-06	3e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CREBBP—prostate cancer	2.78e-06	3e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—EGFR—prostate cancer	2.77e-06	2.99e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—CCND1—prostate cancer	2.77e-06	2.98e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—RXRA—prostate cancer	2.75e-06	2.97e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—MTHFR—prostate cancer	2.75e-06	2.96e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—IGF1—prostate cancer	2.74e-06	2.96e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—PIK3CA—prostate cancer	2.74e-06	2.96e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—CTNNB1—prostate cancer	2.74e-06	2.95e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—MDM2—prostate cancer	2.73e-06	2.95e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—EGFR—prostate cancer	2.73e-06	2.94e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—CYP1A1—prostate cancer	2.71e-06	2.92e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.7e-06	2.91e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PPARA—prostate cancer	2.7e-06	2.91e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MAP2K1—prostate cancer	2.69e-06	2.91e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—ERBB2—prostate cancer	2.69e-06	2.9e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—ERCC2—prostate cancer	2.69e-06	2.9e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—MMP9—prostate cancer	2.69e-06	2.9e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—PIK3CD—prostate cancer	2.68e-06	2.89e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—CDKN1A—prostate cancer	2.68e-06	2.89e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.67e-06	2.89e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—PTEN—prostate cancer	2.67e-06	2.88e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—PIK3CB—prostate cancer	2.66e-06	2.87e-05	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—PIK3CA—prostate cancer	2.65e-06	2.86e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MAP2K1—prostate cancer	2.65e-06	2.86e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—COMT—prostate cancer	2.65e-06	2.86e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—NCOA2—prostate cancer	2.65e-06	2.86e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—SERPINE1—prostate cancer	2.65e-06	2.86e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—GSTP1—prostate cancer	2.64e-06	2.84e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—PIK3CD—prostate cancer	2.63e-06	2.84e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—KRAS—prostate cancer	2.62e-06	2.83e-05	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—PIK3CA—prostate cancer	2.61e-06	2.81e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—AKT1—prostate cancer	2.6e-06	2.81e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—SERPINE1—prostate cancer	2.6e-06	2.81e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—ITPR1—prostate cancer	2.59e-06	2.8e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—KRAS—prostate cancer	2.58e-06	2.78e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PIK3CG—prostate cancer	2.57e-06	2.77e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—FGF2—prostate cancer	2.56e-06	2.76e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CXCL8—prostate cancer	2.55e-06	2.75e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.55e-06	2.75e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—EP300—prostate cancer	2.55e-06	2.75e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—PTEN—prostate cancer	2.55e-06	2.75e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—CAV1—prostate cancer	2.53e-06	2.73e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—MTHFR—prostate cancer	2.53e-06	2.73e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—NOS3—prostate cancer	2.53e-06	2.73e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.53e-06	2.72e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—FGF2—prostate cancer	2.52e-06	2.72e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CDKN1B—prostate cancer	2.49e-06	2.69e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—NOS3—prostate cancer	2.49e-06	2.68e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PPARA—prostate cancer	2.48e-06	2.67e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—SRC—prostate cancer	2.48e-06	2.67e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.47e-06	2.66e-05	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—AKT1—prostate cancer	2.47e-06	2.66e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—JAK2—prostate cancer	2.46e-06	2.65e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—TYMS—prostate cancer	2.45e-06	2.64e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CASP3—prostate cancer	2.44e-06	2.64e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—IL2—prostate cancer	2.44e-06	2.63e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—NQO1—prostate cancer	2.44e-06	2.63e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—INS—prostate cancer	2.43e-06	2.63e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—EP300—prostate cancer	2.43e-06	2.62e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—IL6—prostate cancer	2.43e-06	2.62e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—GSTM1—prostate cancer	2.42e-06	2.61e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.42e-06	2.61e-05	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—AKT1—prostate cancer	2.42e-06	2.61e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—JAK2—prostate cancer	2.42e-06	2.61e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—VEGFA—prostate cancer	2.41e-06	2.6e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—PIK3CA—prostate cancer	2.41e-06	2.6e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—TH—prostate cancer	2.4e-06	2.59e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MDM2—prostate cancer	2.4e-06	2.59e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—STAT3—prostate cancer	2.39e-06	2.58e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—CREBBP—prostate cancer	2.38e-06	2.57e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CCND1—prostate cancer	2.38e-06	2.57e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—LPL—prostate cancer	2.38e-06	2.57e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—PIK3CA—prostate cancer	2.37e-06	2.55e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—ERBB2—prostate cancer	2.36e-06	2.55e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MDM2—prostate cancer	2.36e-06	2.54e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CTNNB1—prostate cancer	2.36e-06	2.54e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.34e-06	2.52e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—PIK3CB—prostate cancer	2.33e-06	2.52e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—CAV1—prostate cancer	2.33e-06	2.52e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—ERBB2—prostate cancer	2.33e-06	2.51e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—MMP9—prostate cancer	2.31e-06	2.49e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PIK3CG—prostate cancer	2.31e-06	2.49e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CDKN1A—prostate cancer	2.3e-06	2.48e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CYP1A1—prostate cancer	2.3e-06	2.48e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—PTEN—prostate cancer	2.3e-06	2.48e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—PIK3CB—prostate cancer	2.3e-06	2.48e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—ERCC2—prostate cancer	2.28e-06	2.46e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—GGT1—prostate cancer	2.27e-06	2.44e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PIK3CD—prostate cancer	2.26e-06	2.44e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CXCL8—prostate cancer	2.24e-06	2.42e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—AKT1—prostate cancer	2.24e-06	2.42e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—NCOA1—prostate cancer	2.23e-06	2.41e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—MYC—prostate cancer	2.22e-06	2.39e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—TGFB1—prostate cancer	2.21e-06	2.39e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CXCL8—prostate cancer	2.21e-06	2.38e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.2e-06	2.37e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—EP300—prostate cancer	2.19e-06	2.36e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CDKN1B—prostate cancer	2.19e-06	2.36e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—INS—prostate cancer	2.19e-06	2.36e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—EGFR—prostate cancer	2.17e-06	2.34e-05	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—AKT1—prostate cancer	2.17e-06	2.34e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CDKN1B—prostate cancer	2.15e-06	2.32e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CASP3—prostate cancer	2.15e-06	2.31e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—IL2—prostate cancer	2.14e-06	2.31e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—MTHFR—prostate cancer	2.14e-06	2.31e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—CREBBP—prostate cancer	2.14e-06	2.31e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—NOS3—prostate cancer	2.14e-06	2.3e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—IL6—prostate cancer	2.13e-06	2.3e-05	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—AKT1—prostate cancer	2.13e-06	2.3e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—SRC—prostate cancer	2.13e-06	2.3e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.12e-06	2.29e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—RXRA—prostate cancer	2.12e-06	2.29e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CASP3—prostate cancer	2.11e-06	2.28e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—IL2—prostate cancer	2.11e-06	2.27e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PPARA—prostate cancer	2.1e-06	2.27e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—IL6—prostate cancer	2.1e-06	2.26e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CCND1—prostate cancer	2.09e-06	2.25e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—VEGFA—prostate cancer	2.07e-06	2.24e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CTNNB1—prostate cancer	2.07e-06	2.23e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CCND1—prostate cancer	2.05e-06	2.22e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—STAT3—prostate cancer	2.05e-06	2.21e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—KRAS—prostate cancer	2.05e-06	2.21e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—COMT—prostate cancer	2.04e-06	2.21e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CTNNB1—prostate cancer	2.03e-06	2.2e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—GSTP1—prostate cancer	2.03e-06	2.19e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PIK3CD—prostate cancer	2.03e-06	2.19e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MMP9—prostate cancer	2.03e-06	2.19e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CDKN1A—prostate cancer	2.02e-06	2.18e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—PTEN—prostate cancer	2.02e-06	2.17e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—INS—prostate cancer	2.01e-06	2.17e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ITPR1—prostate cancer	2e-06	2.16e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MMP9—prostate cancer	2e-06	2.15e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CDKN1A—prostate cancer	1.99e-06	2.14e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—PTEN—prostate cancer	1.98e-06	2.14e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CAV1—prostate cancer	1.98e-06	2.13e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PIK3CB—prostate cancer	1.97e-06	2.13e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.97e-06	2.12e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—AKT1—prostate cancer	1.97e-06	2.12e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PTGS2—prostate cancer	1.95e-06	2.11e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—AKT1—prostate cancer	1.93e-06	2.09e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—EP300—prostate cancer	1.92e-06	2.07e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—NOS3—prostate cancer	1.92e-06	2.07e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—MYC—prostate cancer	1.91e-06	2.06e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—TGFB1—prostate cancer	1.9e-06	2.05e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—TYMS—prostate cancer	1.89e-06	2.04e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—EP300—prostate cancer	1.89e-06	2.04e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.89e-06	2.04e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—PIK3CA—prostate cancer	1.88e-06	2.03e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.87e-06	2.02e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—SRC—prostate cancer	1.87e-06	2.02e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.87e-06	2.01e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—EGFR—prostate cancer	1.87e-06	2.01e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—SRC—prostate cancer	1.84e-06	1.98e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—LPL—prostate cancer	1.84e-06	1.98e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—TP53—prostate cancer	1.82e-06	1.97e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—VEGFA—prostate cancer	1.82e-06	1.96e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—STAT3—prostate cancer	1.8e-06	1.94e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.8e-06	1.94e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—PIK3CA—prostate cancer	1.8e-06	1.94e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—VEGFA—prostate cancer	1.79e-06	1.93e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—STAT3—prostate cancer	1.77e-06	1.91e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.77e-06	1.91e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.77e-06	1.91e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—NOS3—prostate cancer	1.76e-06	1.9e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—KRAS—prostate cancer	1.76e-06	1.9e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.76e-06	1.9e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PTGS2—prostate cancer	1.75e-06	1.89e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PTEN—prostate cancer	1.7e-06	1.84e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—INS—prostate cancer	1.7e-06	1.84e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MYC—prostate cancer	1.68e-06	1.81e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—TGFB1—prostate cancer	1.67e-06	1.8e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CREBBP—prostate cancer	1.67e-06	1.8e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—IL6—prostate cancer	1.67e-06	1.8e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.65e-06	1.78e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MYC—prostate cancer	1.65e-06	1.78e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—TGFB1—prostate cancer	1.64e-06	1.77e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—EGFR—prostate cancer	1.64e-06	1.77e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.63e-06	1.76e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—EP300—prostate cancer	1.62e-06	1.75e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PPARA—prostate cancer	1.62e-06	1.75e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	1.62e-06	1.75e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PTGS2—prostate cancer	1.61e-06	1.74e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—EGFR—prostate cancer	1.61e-06	1.74e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.58e-06	1.71e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—TP53—prostate cancer	1.57e-06	1.69e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—KRAS—prostate cancer	1.55e-06	1.67e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—AKT1—prostate cancer	1.54e-06	1.66e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PTEN—prostate cancer	1.53e-06	1.65e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CAV1—prostate cancer	1.52e-06	1.64e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—KRAS—prostate cancer	1.52e-06	1.64e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—NOS3—prostate cancer	1.49e-06	1.61e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—AKT1—prostate cancer	1.47e-06	1.58e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—EP300—prostate cancer	1.46e-06	1.57e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—IL6—prostate cancer	1.43e-06	1.55e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—PIK3CA—prostate cancer	1.42e-06	1.53e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PTEN—prostate cancer	1.41e-06	1.52e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—PIK3CA—prostate cancer	1.4e-06	1.51e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.39e-06	1.5e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.38e-06	1.49e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—TP53—prostate cancer	1.38e-06	1.48e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PTGS2—prostate cancer	1.37e-06	1.47e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—TP53—prostate cancer	1.35e-06	1.46e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—EP300—prostate cancer	1.34e-06	1.45e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—AKT1—prostate cancer	1.32e-06	1.43e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—INS—prostate cancer	1.31e-06	1.42e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CREBBP—prostate cancer	1.29e-06	1.39e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—IL6—prostate cancer	1.26e-06	1.36e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—IL6—prostate cancer	1.24e-06	1.34e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.22e-06	1.32e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PIK3CA—prostate cancer	1.2e-06	1.3e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PTEN—prostate cancer	1.19e-06	1.28e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—AKT1—prostate cancer	1.16e-06	1.25e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—NOS3—prostate cancer	1.15e-06	1.24e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—AKT1—prostate cancer	1.14e-06	1.23e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—EP300—prostate cancer	1.14e-06	1.23e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.08e-06	1.16e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.06e-06	1.15e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PTGS2—prostate cancer	1.05e-06	1.14e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PIK3CA—prostate cancer	9.92e-07	1.07e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—AKT1—prostate cancer	9.82e-07	1.06e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PTEN—prostate cancer	9.19e-07	9.92e-06	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—AKT1—prostate cancer	8.81e-07	9.5e-06	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—EP300—prostate cancer	8.77e-07	9.46e-06	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PIK3CA—prostate cancer	8.4e-07	9.07e-06	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—AKT1—prostate cancer	8.1e-07	8.74e-06	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—AKT1—prostate cancer	6.87e-07	7.41e-06	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PIK3CA—prostate cancer	6.49e-07	7e-06	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—AKT1—prostate cancer	5.3e-07	5.72e-06	CbGpPWpGaD
